Core Viewpoint - Uterine fibroids, known as the most common benign tumors of the female reproductive system, affect a significant percentage of women, particularly those aged 30 to 50, and require careful management and understanding of treatment options [1][2]. Group 1: Prevalence and Characteristics - Uterine fibroids are the most common benign tumors in women, with a lifetime prevalence of 30% to 50% among females [2]. - They are primarily composed of smooth muscle cells and a small amount of fibrous connective tissue, and are more common in women of reproductive age [2][3]. Group 2: Causes and Growth - The exact cause of uterine fibroids remains unclear, but they are believed to be related to female sex hormones, particularly during the reproductive years [3]. - Growth patterns vary, with some women developing multiple fibroids, which can increase in size at a rate of 1-2 cm per year, while rapid growth (over 5 cm in a year) may indicate a risk of malignancy [4]. Group 3: Symptoms and Impact - Many women with uterine fibroids experience no symptoms, but some may have changes in menstruation, abdominal masses, or pressure symptoms affecting urinary and bowel function [5][6]. - Severe symptoms can lead to complications such as anemia and chronic pain, necessitating surgical intervention [6][10]. Group 4: Treatment Options - Treatment options for uterine fibroids include surgery, medication, and non-invasive procedures, tailored to the patient's specific situation [7]. - Surgical options range from myomectomy to hysterectomy, while medication may include hormonal treatments to manage symptoms [7][8]. Group 5: Indications for Surgery - Not all uterine fibroids require surgery; indications include significant symptoms such as heavy menstrual bleeding, pain, or pressure effects on surrounding organs [8][9][10]. - Rapid growth of fibroids or changes in size post-menopause also warrant surgical evaluation [13]. Group 6: Post-Surgery Considerations - There is a possibility of fibroid recurrence post-surgery, particularly in cases of multiple fibroids, necessitating regular follow-up and monitoring [14]. Group 7: Lifestyle and Management - Patients are advised to maintain a healthy lifestyle, including a balanced diet, regular exercise, and stress management, while avoiding estrogen-containing supplements that may exacerbate fibroid growth [15][16].